AMA Ed Hub Logo

Learn more on prescription drugs from AMA Ed Hub™
Red JAMA Logo

Learn more on prescription drugs from JAMA Network™
2025 Annual Meeting of the HOD

Learn more on prescription drugs from PolicyFinder
United States Adopted Names Council

United States Adopted Names (USAN)
Clear Search
AMA Update for May 24, 2024: How to find reliable health information, weight loss drug research, and GLP-1 side effects
·
11 Min Read

How to find reliable health information, weight loss drug research and GLP-1 side effects

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about how to find reliable health information on topics such as weight loss drugs and more.

series
Chronic Diseases
AMA Update
·
4 Min Read

Top news stories from AMA Morning Rounds®: Week of May 13, 2024

In the news: Cardiovascular-kidney-metabolic syndrome, threat of cyberattacks for health care industry, weight loss maintenance with semaglutide and more.

Publications & Newsletters
·
4 Min Read

Top news stories from AMA Morning Rounds®: Week of May 6, 2024

In the news: Generic drug shortages, olive oil lowers dementia-related mortality, Ascension cybersecurity incident impacts 140 hospitals and more.

Publications & Newsletters
Patient standing at reception desk and completing paperwork at medical appointment
·
3 Min Read

Health spending back to pre-COVID rates—but not for physicians

Spending on prescription drugs grew at nearly triple the rate of national spending for physician services. Dive into the data with the AMA.

Public Health Advocacy
·
4 Min Read

Top news stories from AMA Morning Rounds®: Week of April 15, 2024

In the news: Few Americans get 8 hours of sleep a night, health care top target for cyberattacks, 340B program dispute resolution and more.

Publications & Newsletters
Federal Trade Commission Chair Lina Khan speaking at the AMA National Advocacy Conference
·
4 Min Read

FTC eyes how “middlemen” contribute to generic drug shortages

“Corporate middlemen can have an outsized say in how you do your jobs as physicians,” Federal Trade Commission (FTC) Chair Lina Khan tells doctors.

Behavioral Health
Woman sitting on couch looking out a window
·
5 Min Read

Reducing access to mifepristone would harm patients

Scientific evidence overwhelmingly demonstrates mifepristone’s safety. Reimposing limits on its use will harm patients and undermine the nation’s longstanding drug-approval system.

series
Leadership
Leadership Viewpoints
A cherry tree in bloom near the U.S. Supreme Court
·
5 Min Read

Why high court shouldn’t interfere with FDA’s science-based decisions

Mifepristone saves lives and is as safe as ibuprofen. The AMA and other medical associations urge the Supreme Court to respect FDA expertise, authority.

Judicial Advocacy
·
5 Min Read

Top news stories from AMA Morning Rounds®: Week of March 11, 2024

In the news: Medicare drug price negotiations, ongoing fallout from hack of UnitedHealth’s Change Healthcare, data errors in maternal mortality rate and more.

Publications & Newsletters